|
1
|
Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display.
|
PLoS Pathog
|
2005
|
3.01
|
|
2
|
Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport.
|
Eukaryot Cell
|
2006
|
2.55
|
|
3
|
Aspergillus fumigatus: principles of pathogenesis and host defense.
|
Eukaryot Cell
|
2007
|
1.74
|
|
4
|
The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy.
|
Infect Immun
|
2005
|
1.68
|
|
5
|
A role for the unfolded protein response (UPR) in virulence and antifungal susceptibility in Aspergillus fumigatus.
|
PLoS Pathog
|
2009
|
1.42
|
|
6
|
Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells.
|
Cancer Immunol Immunother
|
2008
|
1.30
|
|
7
|
Neutropenia alters lung cytokine production in mice and reduces their susceptibility to pulmonary cryptococcosis.
|
Eur J Immunol
|
2003
|
1.30
|
|
8
|
Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3.
|
Infect Immun
|
2002
|
1.24
|
|
9
|
Unexpected link between metal ion deficiency and autophagy in Aspergillus fumigatus.
|
Eukaryot Cell
|
2007
|
1.10
|
|
10
|
Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay.
|
J Clin Microbiol
|
2011
|
1.08
|
|
11
|
Induced humoral immunity and vaccination against major human fungal pathogens.
|
Curr Opin Microbiol
|
2002
|
0.98
|
|
12
|
Detection of urinary excreted fungal galactomannan-like antigens for diagnosis of invasive aspergillosis.
|
PLoS One
|
2012
|
0.94
|
|
13
|
Laccase expression in murine pulmonary Cryptococcus neoformans infection.
|
Infect Immun
|
2005
|
0.92
|
|
14
|
Mouse models for the study of fungal pneumonia: a collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due to Aspergillus-Rhizopus.
|
Virulence
|
2012
|
0.91
|
|
15
|
Voriconazole inhibits fungal growth without impairing antigen presentation or T-cell activation.
|
Antimicrob Agents Chemother
|
2003
|
0.89
|